Abstract
This is the report of the 2nd Joint ENCCA/EuroSARC European Bone Sarcoma Network Meeting held in Leiden, The Netherlands, on 26-27 September 2013, bringing together preclinical and clinical investigators on bone sarcoma. The purpose of this workshop was to present the achievements of biological research and clinical trials in bone sarcomas and to stimulate crosstalk.
Highlights
Jakob K Anninga1, Anne-Marie Cleton-Jansen1, Bass Hassan2, M Fernanda Amary3, Daniel Baumhoer4, Jean-Yves Blay5, Laurence Brugieres6, Stefano Ferrari7, Heribert Jürgens8, Beate Kempf-Bielack9, Heinrich Kovar10, Ola Myklebost11, Michaela Nathrath12, Piero Picci7, Peter Riegman13, Marco W Schilham1, Ranin Soliman14, Dan P Stark15, Sandra Strauss16, Matthew Sydes17, Patrick Tarpey18, David Thomas19, Jeremy Whelan16, Miriam Wilhelm9, Manal Zamzam14, Hans Gelderblom1† and Stefan S Bielack8,9*. This is the report of the 2nd Joint ENCCA/EuroSARC European Bone Sarcoma Network Meeting held in Leiden, The Netherlands, on 26-27 September 2013, bringing together preclinical and clinical investigators on bone sarcoma
The meeting was organized by Stefan Bielack, representing ENCCA (European Network for Cancer research in Children and Adolescents, Work Package 7 (Bone sarcomas)), Bass Hassan, representing EuroSARC (EUROpean clinical trials in rare SARComas within an integrated translational trial network), Anne-Marie Cleton-Jansen representing both and Pauline de Graaf (Leiden, The Netherlands), representing both
Preclinical studies have provided a wealth of new data, requiring renewed bioinformatic analyses
Summary
This is the report of the 2nd Joint ENCCA/EuroSARC European Bone Sarcoma Network Meeting held in Leiden, The Netherlands, on 26-27 September 2013, bringing together preclinical and clinical investigators on bone sarcoma. The meeting was organized by Stefan Bielack, representing ENCCA (European Network for Cancer research in Children and Adolescents, Work Package 7 (Bone sarcomas)), Bass Hassan, representing EuroSARC (EUROpean clinical trials in rare SARComas within an integrated translational trial network), Anne-Marie Cleton-Jansen representing both and Pauline de Graaf (Leiden, The Netherlands), representing both. The purpose of this workshop was to present the achievements and current status of biological and translational research and clinical trials in bone sarcomas and to stimulate crosstalk. Future work will be to establish a dedicated panel of genes for the identification of drivers and pathways, and analysis of the data in the clinical context of subtypes, prognosis and potential targets for treatment
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
